statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Orgenesis Inc. (NASDAQ:ORGS - Get Free Report)'s stock price traded down 33.4% during trading on Tuesday . The stock traded as low as $0.30 and last traded at $0.39. 1,041,563 shares traded hands...

Orgenesis (NASDAQ:ORGS)  Shares Down 33.4%

GERMANTOWN, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) ( Orgenesis or the Company ), a global leader in decentralizing cell and gene therapies (CGTs), today announced...

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Orgenesis awarded EUR 1.5M grant from Walloon Government

GERMANTOWN, Md., March 13, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) ( Orgenesis or the Company ), a global leader in decentralizing cell and gene therapies (CGTs), today announced...

Orgenesis Consortium Awarded  1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes

Orgenesis Inc. ( NASDAQ:ORGS ) shares have had a really impressive month, gaining 119% after a shaky period beforehand...

Orgenesis Inc.'s (NASDAQ:ORGS) Price Is Right But Growth Is Lacking After Shares Rocket 119%

Orgenesis announces $2.3M private placement...

Orgenesis announces $2.3M private placement

GERMANTOWN, Md., March 04, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) ( Orgenesis or the Company ), a global leader in decentralized cell and gene therapies (CGTs), announced today...

Orgenesis Inc. Announces $2.3 Million Private Placement

GERMANTOWN, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) ( Orgenesis or the Company ), a global leader in decentralized cell and gene therapies (CGTs), today announced that...

Orgenesis Consortium Awarded  2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing

GERMANTOWN, Md., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) ( Orgenesis or the Company ), a global leader in decentralizing cell and gene therapies (CGTs), today announced it...

Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic

Orgenesis Inc. (NASDAQ:ORGS  Get Free Report) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totalling 120,500 shares, a drop of...

Short Interest in Orgenesis Inc. (NASDAQ:ORGS) Declines By 36.4%

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.

Volume	9,470.00
52-Wk High	$1.50
52-Wk Low	$0.25

ORGS Orgenesis Inc

About

Feed

News

Sentiment

Earnings

Fundamentals